TheProfitWatch

IBIO - iBio, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
0.96 0.09 (9.39%) --- 0.0 (0.0%) 0.01 (0.48%) 0.03 (2.6%) 0.05 (5.0%) -0.01 (-1.01%) -0.01 (-0.52%)

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.75
Diluted EPS:
-1.75
Basic P/E:
-0.6
Diluted P/E:
-0.6
RSI(14) 1m:
62.5
VWAP:
1.05
RVol:

Events

Period Kind Movement Occurred At

Related News